Results 71 to 80 of about 3,656,183 (130)

The heart in inherited metabolic disorders: lysosomal and glycogen storage diseases

open access: yes, 2018
Lysosomal storage diseases (LSDs) represent a large and heterogeneous group of rare inherited disorders caused by a defective function of one of the lysosomal acid hydrolases, their activator proteins, or proteins necessary for intracellular trafficking.
Ales Linhart
core   +1 more source

Common and uncommon pathogenic cascades in lysosomal storage diseases.

open access: yes, 2016
Lysosomal storage diseases (LSDs), of which about 50 are known, are caused by the defective activity of lysosomal proteins, resulting in accumulation of unmetabolized substrates. As a result, a variety of pathogenic cascades are activated such as altered

core   +1 more source

Lysosomal diseases: Overview on current diagnosis and treatment

open access: yesGenetics and Molecular Biology, 2019
Lysosomal diseases (LDs), also known as lysosomal storage diseases (LSDs), are a heterogeneous group of conditions caused by defects in lysosomal function.
Fabiano de Oliveira Poswar   +8 more
doaj   +1 more source

Perinatal Gene Transfer to the Liver [PDF]

open access: yes, 2011
The liver acts as a host to many functions hence raising the possibility that any one may be compromised by a single gene defect. Inherited or de novo mutations in these genes may result in relatively mild diseases or be so devastating that death within
Buckley, SM   +20 more
core   +1 more source

Haematopoietic development and immunological function in the absence of cathepsin D [PDF]

open access: yes, 2007
Background: Cathepsin D is a well-characterized aspartic protease expressed ubiquitously in lysosomes. Cathepsin D deficiency is associated with a spectrum of pathologies leading ultimately to death.
Calogero Tulone   +17 more
core   +1 more source

Lysosomal Ca(2+) homeostasis: role in pathogenesis of lysosomal storage diseases.

open access: yes, 2011
Disrupted cellular Ca(2+) signaling is believed to play a role in a number of human diseases including lysosomal storage diseases (LSD). LSDs are a group of ∼50 diseases caused predominantly by mutations in lysosomal proteins that result in accumulation ...
Platt, Frances M.   +3 more
core   +1 more source

Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis.

open access: yes, 2002
Paediatric neurodegenerative diseases are frequently caused by inborn errors in glycosphingolipid (GSL) catabolism and are collectively termed the glycosphingolipidoses.
M. Jeyakumar   +3 more
core   +1 more source

Lysosomal storage diseases in non-immune hydrops fetalis pregnancies.

open access: yes, 2006
Contains fulltext : 50653.pdf (Publisher’s version ) (Open Access)BACKGROUND: At least 20 inborn errors of metabolism may cause hydrops fetalis. Most of these are lysosomal storage diseases. The study proposes a diagnostic flowchart for
Pim M.W. Janssens   +29 more
core   +1 more source

Effect of disease progression on CSF-directed AAV gene therapy in a large brain animal model of lysosomal storage disease

open access: yesMolecular Therapy: Methods & Clinical Development
The lysosomal storage disease alpha-mannosidosis (AMD) is caused by a genetic deficiency of lysosomal alpha-mannosidase, leading to the widespread presence of storage lesions in the brain and other tissues.
Jacqueline E. Hunter   +6 more
doaj   +1 more source

The emerging role and clinicopathological significance of MFSD12 in cancer and lysosomal storage diseases [PDF]

open access: yes
MFSD12 protein has recently risen as a key factor in malignancy and plays a potential role in a variety of complex oncogenic signaling cascades. Current studies suggest that MFSD12 has a positive complex role in the growth and progression of tumors such ...
Liqiong Ding
core   +1 more source

Home - About - Disclaimer - Privacy